The gene encoding the membrane (M) protein of the OC43 strain of human coronavirus (HCV-OC43) was amplified by a reverse transcription-polymerase chain reaction of viral RNA with HCV-OC43-and bovine coronavirus (BCV)-specific primers. The nucleotide sequence of the cloned 1-5 kb fragment revealed an open reading frame (ORF) of 690 nucleotides which was identified as the M protein gene from its homology to BCV. This ORF encodes a protein of 230 amino acids with an Mr of 26416. The gene is preceded by the motif UCCAAAC, analogous to the consensus coronavirus transcription initiation sequence. The M protein of HCV-OC43 shows features typical of all coronavirus M proteins studied: a hydrophilic, presumably external N terminus including about 10 % of the protein, and a potential N-glycosylation site followed by three major hydrophobic transmembrane domains. The amino acid sequence of the M protein of HCV-OC43 has 94% identity with that of the Mebus strain of BCV, and also contains six potential O-glycosylation sites in the exposed N-terminal domain. Indeed, the glycosylation of the M protein was not inhibited in the presence of tunicamycin, which is indicative of O-glycosylation, as previously reported for BCV and murine hepatitis virus. Virions released from tunicamycin-treated cells contained the M glycoprotein but were devoid of both peplomer (S) and haemagglutinin-esterase (HE) proteins. Thus, inhibition of the N-glycosylation of the S and HE structural proteins prevented their incorporation into progeny virions, an indication that they are dispensable for virion morphogenesis, unlike the M protein.
The gene encoding the membrane (M) protein of the OC43 strain of human coronavirus (HCV-OC43) was amplified by a reverse transcription-polymerase chain reaction of viral RNA with HCV-OC43-and bovine coronavirus (BCV)-specific primers. The nucleotide sequence of the cloned 1-5 kb fragment revealed an open reading frame (ORF) of 690 nucleotides which was identified as the M protein gene from its homology to BCV. This ORF encodes a protein of 230 amino acids with an Mr of 26416. The gene is preceded by the motif UCCAAAC, analogous to the consensus coronavirus transcription initiation sequence. The M protein of HCV-OC43 shows features typical of all coronavirus M proteins studied: a hydrophilic, presumably external N terminus including about 10 % of the protein, and a potential N-glycosylation site followed by three major hydrophobic transmembrane domains. The amino acid sequence of the M protein of HCV-OC43 has 94% identity with that of the Mebus strain of BCV, and also contains six potential O-glycosylation sites in the exposed N-terminal domain. Indeed, the glycosylation of the M protein was not inhibited in the presence of tunicamycin, which is indicative of O-glycosylation, as previously reported for BCV and murine hepatitis virus. Virions released from tunicamycin-treated cells contained the M glycoprotein but were devoid of both peplomer (S) and haemagglutinin-esterase (HE) proteins. Thus, inhibition of the N-glycosylation of the S and HE structural proteins prevented their incorporation into progeny virions, an indication that they are dispensable for virion morphogenesis, unlike the M protein.
Human coronaviruses (HCVs) are grouped into two major antigenic clusters, represented by the prototype strains 229E and OC43 (Siddell et al., 1983) . HCV-OC43 shares antigenic relationships with other coronaviruses such as mouse hepatitis virus (MHV), rat sialodacryadenitis virus, porcine haemagglutinating encephalomyelitis virus, bovine coronavirus (BCV) and rabbit coronavirus. HCV-229E is the prototype strain of another antigenic group which includes porcine transmissible gastroenteritis virus (TGEV), porcine respiratory coronavirus, canine coronavirus, feline enteric coronavirus and feline infectious peritonitis virus (FIPV).
HCVs are recognized as the causative agents of respiratory diseases, being responsible for about 15~o of common colds (McIntosh, 1974) . Other disease associations have been suggested but are less well documented, for example the involvement of HCV in severe diarrhoea (Resta et al., 1985) or neurological disease such as multiple sclerosis (Burks et al., 1980; Weiss, 1983) .
The nucleotide sequence data reported in this paper will appear in the EMBL and GenBank Nucleotide Sequence Databases under the accession number M93390.
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MHVs show diverse tropisms, and some MHV strains in rodents have been used as a model system to study chronic and acute hepatic and neurological diseases.
Coronaviruses contain a capped and polyadenylated positive-sense ssRNA molecule of 27 to 31 kb (Boursnell et aL, 1987; Lee et aL, 1991) . Virus-specific mRNAs in infected cells comprise a genomic-sized mRNA plus four to eight subgenomic mRNA species. These mRNAs are arranged in a Y-coterminal nested set structure, in which the sequence of each mRNA is contained within the sequence of the next larger mRNA. The mRNAs appear to be formed by a mechanism of leader-primed transcription, and a consensus intergenic sequence is the proposed site of fusion of the leader sequence with the mRNA coding region (Lai, 1990) .
Previous studies have identified four HCV-OC43 structural proteins: a 190K peplomer (S) glycoprotein (normally present as subunits of 120K and 100K), a 130K haemagglutinin-esterase (HE) glycoprotein, a 55K nucleocapsid (N) phosphoprotein and a 26K membrane (M) glycoprotein (Hogue & Brian, 1986) . Various studies have reported remarkable antigenic and genomic similarities between HCV-OC43 and BCV (Hogue et al., (Vennema et al., 1991) , HCV-229E (Jouvenne et al., 1990) and IBV (Boursnell et al., 1984) ] by alignment for maximum identity. Dots indicate residues identical to those of HCV-OC43; hyphens represent gaps introduced into the sequence. The analysis was performed with the GeneWorks 2.0 program (IntelliGenetics) using default settings.
4h post-infection, 2.5mCi [3SS]methionine/cysteine (Trans3SS-Label, ICN Biomedical) was added, after a 1 h methionine and cysteine deprivation period. After 2 h, unlabelled methionine and cysteine were added, as was foetal bovine serum, and infection was allowed to proceed for another 39 h. Radiolabelled virions produced in the presence or absence of tunicamycin were purified on Renografin-60 gradients and structural proteins were analysed as described previously (Arpin & Talbot, 1990) . The complete nucleotide sequence of the HCV-OC43 M gene and its predicted amino acid sequence are shown in Fig. 1 , together with potential glycosylation sites and intergenic consensus sequences. The largest open reading frame (ORF) (nucleotides 33 to 725) encodes a protein of 230 amino acids with a predicted Mr of 26 416, consistent with the estimated Mr of the M protein of HCV-OC43 determined by SDS-PAGE (Hogue & Brian, 1986; Schmidt & Kenny, 1982; Fig. 3) .
As shown in Fig. 2 , the M protein of HCV-OC43 is very similar to the corresponding protein of the Mebus strain of BCV (Lapps et al., 1987) , which is antigenically related. Indeed, extensive identity exists between the HCV-OC43 and both BCV and turkey coronavirus (TCV) M proteins at the amino acid level (94~o). An identity of 83 to 84~o is found between the M proteins of HCV-OC43 and the A59 and JHM strains of MHV, which belong to the same antigenic group. On the other hand, the M proteins of the antigenically distinct TGEV, FIPV, HCV-229E and infectious bronchitis virus (IBV) show only 37, 35, 32 and 26~ identity to that of HCV-OC43, respectively. The M proteins of both HCV-OC43 and BCV are composed of the same number of residues. Moreover, they also possess identical numbers of basic and acidic amino acids, and are predicted to have similar Mrs. The M protein of HCV-OC43 contains three cysteine residues (positions 74, 126 and 183), whereas BCV lacks the C-terminal one of these. An intergenic sequence, UCCAAAC, identical to the one observed in front of the BCV M gene (Lapps et al., 1987) and some other coronavirus genes [BCV mRNAs 4 and 5 (Abraham et aL, 1990); MHV-A59 M gene (Armstrong et al., 1984) ; MHV-JHM M gene (Pfleiderer et al., 1986) ] is present 10 nucleotides upstream of the predicted initiation codon of the HCV-OC43 M protein (Fig. 1) .
Like those of BCV, TCV and MHV, there is one potential N-glycosylation site in the predicted HCV-OC43 M protein sequence (Asn 26); it is located near the N-terminal, presumably exposed portion of the molecule. Two such exposed sites are found in IBV, TGEV and FIPV, whereas one of three sites in HCV-229E is predicted to be external. However, since the M protein has previously been shown to be O-glycosylated in both BCV (Deregt et al., 1987) and MHV (Holmes et al., 1981 ; Niemann & Klenk, 1981) , we used the N-glycosylation inhibitor tunicamycin to verify the type of glycosylation found on HCV-OC43 glycoproteins. As shown in Fig. 3 , virions produced in the presence of this drug were completely devoid of both S (180K, 105K and 80K forms) and HE (125K and 65K forms) proteins, but still contained the three forms (28K, 27K and 26K) of the M protein that have previously been shown to be glycosylated (Hogue & Brian, 1986) . Therefore, it appears that the M protein of HCV-OC43 is also O-glycosylated. Indeed, six potential O-glycosylation sites are found in the external portion of the molecule (Fig. 1) . These sites are conserved in both BCV and MHV (Fig. 2) . The extensive identity of the sequence of the M proteins of HCV-OC43 and BCV confirms previous reports of a close relationship between these two viruses revealed by serological analysis (Pedersen et aL, 1978; Gerna et al., 1981) , immunoprecipitation of virion structural proteins (Hogue et al., 1984) , oligonucleotide fingerprinting of genomic R N A (Lapps & Brian, 1985) and phylogenetic analysis of the H E gene (Zhang et al., 1992) . Moreover, alignment of the sequences of the N proteins of HCV-OC43 and BCV has revealed 97.5% identity (Kamahora et al., 1989) . We now find 94% identity between the M proteins of HCV-OC43 and BCV. Together, these findings suggest that these two viruses have diverged from each other only recently. Interestingly, these viruses share the same target cell specificity in vitro, but apparently show different tropisms in vivo. Furthermore, HCV-OC43 causes mainly respiratory illness in man, whereas BCV affects mainly the gastrointestinal system of cattle. The causes of these differences are not known. However, differences between the two viruses have been detected at the level of some non-structural protein genes (S. Mounir & P. J. Talbot, unpublished results). Sequence variations of the S glycoprotein could also be involved, as suggested previously for the murine and porcine coronaviruses (Parker et al., 1989; Rasschacrt et al., 1990) . The possibility remains that an HCV-OC43-1ike coronavirus could be involved in enteric infections (Gerna et al., 1985) , although serologically unrelated HCVs have also been reported (Resta et al., 1985) .
The intergenic region U C C A A A C upstream of the M gene of HCV-OC43 has also been identified for the M genes of BCV (Lapps et al., 1987) and two strains of MHV (Armstrong et al., 1984; Pfleiderer et aL, 1986) . The only other reported occurrence of this exact sequence is in mRNAs 4 and 5 of BCV (Abraham et al., 1990 ). This conserved sequence shows only one nucleotide difference to the postulated UCUAAAC consensus leader RNA binding site found in 23 of 33 published animal coronavirus gene sequences (data not shown).
Comparison of the hydropathy profiles of all known coronavirus M proteins (data not shown) shows that the expected membrane topology (three hydrophobic domains) is likely to resemble the proposed model (Rottier et al., 1986; Armstrong et al., 1984) . Most of the basic amino acids are present in the C-terminal half of the protein, and therefore might interact with the negatively charged RNA and the acidic residues of the N protein (Sturman et al., 1980) . Interestingly, only TGEV and FIPV possess an N-terminal hydrophobic sequence.
The glycosylation of the HCV-OC43 M protein was not sensitive to the inhibitory effect of tunicamycin, which is indicative of O-glycosylation, as has been reported previously for MHV (Holmes et al., 1981; Niemann & Klenk, 1981) and BCV (Deregt et al., 1987) . On the other hand, both the S and the HE proteins of HCV-OC43 were sensitive to this drug and therefore are likely to be N-glycosylated. Interestingly, the nonglycosylated precursors of these proteins could not be detected on purified virions, which is consistent with the absence of non-glycosylated S protein from MHV virions (Holmes et al., 1981) . Our results suggest that the HE protein is also dispensable for the formation of the viral envelope and virus maturation and release, unlike the M protein.
As shown in Fig. 3 , other apparently structural viral proteins were observed in addition to the three envelope glycoproteins and the N protein. Of the large proteins, those with apparent Mrs of 240K, 155K and 38K have also been observed in BCV and associated with S, N and M proteins, respectively{-t- Iogue & Brian, 1986) . We also found small proteins (22-5K and 17K) and a 45K molecule, which appears to be the reduced form of a larger protein, possibly p240, which disappears upon reduction.
Six potential O-glycosylation sites are observed within the first 28 N-terminal residues of the HCV-OC43 M protein. Moreover, there is one potential site for Nglycosylation in this region. This site is conserved at the same relative position in all known sequences of coronavirus M proteins except those of IBV and HCV-229E (Fig. 2) , although it is apparently not utilized in HCV-OC43, BCV and MHV.
The relative conservation of the M proteins of coronaviruses suggests that structural constraints on this protein are rigid, resulting in more limited evolution of this protein. The study of the remainder of the genome of HCV-OC43 should yield important information on the replication, tropism and pathogenesis of this important human pathogen. Such studies are in progress.
